ASCO 2019 | Current approaches to treating urothelial cancer
Jeanny Aragon-Ching, MD, FACP, of the Inova Schar Cancer Institute, Fairfax, VA, discusses current approaches to treating urothelial cancer and their limitations. She specifically mentions cisplatin-based therapy and the differenced that arise when treating ovarian cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.
Get great new content delivered to your inboxSign up